Searching in Healthcare · Search everything
597 changes
FDA Complaint Document Details
The FDA has posted details regarding a complaint document, with the information made available on March 16, 2026. The document is related to a complaint filed with the agency.
FDA Variance Application from J.M.W. Entertainment Group
The FDA has posted a variance application from The J.M.W. Entertainment Group, LLC. This document is available for review on the Regs.gov platform. No further details on the nature of the variance or its implications are provided in the notice.
FDA Acknowledgment Letter to Audio Source, Inc
The FDA has issued an acknowledgment letter to Audio Source, Inc. regarding a submission. This notice confirms receipt of the document by the agency.
FDA Complaint Posted for Public Comment
The FDA has posted a complaint for public comment, with the comment period closing on March 16, 2026. This action allows for public input on a specific complaint filed with the agency.
FDA Acknowledgment Letter to J.M.W. Entertainment Group
The FDA issued an acknowledgment letter to The J.M.W. Entertainment Group, LLC, regarding a submission. This notice confirms receipt of documentation by the FDA's Center for Devices and Radiological Health (CDRH).
FDA Complaint Document
The FDA has posted a complaint document related to its activities, with the comment period closing on March 16, 2026. The document is available for public review and input.
FDA Variance Amendment from J.M.W. Entertainment Group
The FDA has posted a variance amendment from J.M.W. Entertainment Group, LLC. The document was made available on March 16, 2026, via the Regs.gov portal. No further details on the amendment's content are provided.
FDA Progestins Classification and Pharmacology
The Food and Drug Administration (FDA) has published a document detailing the classification and pharmacology of progestins. This guidance provides information for manufacturers and pharmaceutical companies regarding these substances.
FDA Document on Contraceptive Status Among Females 15-49
The Food and Drug Administration (FDA) has issued a document concerning contraceptive status among females aged 15-49. This notice provides information on the topic without introducing new regulatory requirements.
FDA Variance Application from Audio Source, Inc
The FDA has posted a variance application from Audio Source, Inc. This document is available for review on the Regs.gov platform. The application pertains to medical device regulations.
Get alerts for ""
We'll email you when new changes match this search.
Free. Unsubscribe anytime.